Last reviewed · How we verify
NCT06660771
Evaluation of Functional Orthodontic Treatment on Sleep Quality
NA trial testing Functional orthodontic treatment in Sleep Apnea Syndromes in Children in 46 participants. Completed in 28 May 2024.
28 January 2024
Quick facts
| Lead sponsor | Gökçenur Gökçe Kara |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 46 |
| Start date | 5 May 2021 |
| Primary completion | 28 January 2024 |
| Estimated completion | 28 May 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Functional orthodontic treatment
Conditions studied
- Sleep Apnea Syndromes in Children — all drugs for Sleep Apnea Syndromes in Children →
- Functional Orthodontic Treatment — all drugs for Functional Orthodontic Treatment →
- Mandibular Retrognathia — all drugs for Mandibular Retrognathia →
- Upper Airway — all drugs for Upper Airway →
Sponsor
Gökçenur Gökçe Kara
Who can join
Adults 11 to 15, any sex, with Sleep Apnea Syndromes in Children or Functional Orthodontic Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Functional appliances are used in the treatment of Class II anomalies caused by mandibular rethrognathia. Herbst which is a fixed and rigid functional appliance and TWB which is removable appliance can be successful in the treatment of mandibular retrognathia in a short period of six to eight months during the pubertal growth phase. An increase in the upper airway size occurs as a result of functional orthopedic treatment devices eliminating the problem of mandibular retrognathia and stimulating mandibular growth. The aim of this randomized controlled trial was to evaluate the effects of TWB and Herbst appliances on sleep quality in children with obstructive sleep apnea. The null hypothesis was that there is no difference for the sleep quality between the appliances.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06660771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06660771 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gökçenur Gökçe Kara
- Last refreshed: 28 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06660771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing